Old Web
English
Sign In
Acemap
>
authorDetail
>
Eda Caliskan Yildirim
Eda Caliskan Yildirim
Cancer research
Irinotecan
first line
Biology
Oxaliplatin
2
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Could miR34a be as a Potential Biomarker for Doxorubicin Induced Cardiotoxicity
2021
Eda Caliskan Yildirim
Emre Gedik
Gurcan Gunaydin
Cem Çöteli
Necla Ozer
Aysegul Uner
Deniz Yuce
Alev Turker
Show All
Source
Cite
Save
Citations (0)
KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer
2019
Expert Review of Molecular Diagnostics
Yakup Ergün
Yusuf Açıkgöz
Oznur Bal
Gökhan Uçar
Merve Dirikoc
Eda Caliskan Yildirim
Nadiye Akdeniz
Dogan Uncu
Show All
Source
Cite
Save
Citations (3)
1